Research Article

Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS

Table 6

Effects of monomeric compounds on the proliferation of HSC-LX2 cells (mean ± SD, n = 3).

GroupDose (μg·mL−1)ODInhibition ratio (%)

Solvent control0.164 ± 0.012

Blank control01.210 ± 0.070

Model group(TGF-β1)0.13.325 ± 0.138##

BJRG600.939 ± 0.10475.46 ± 2.11

Apigenin152.746 ± 0.16718.33 ± 1.48
301.816 ± 0.04647.72 ± 1.93
601.071 ± 0.10771.32 ± 2.41

5-Methoxypsoralen153.337 ± 0.128
303.382 ± 0.130
603.454 ± 0.117

Apiin153.238 ± 0.177##2.73 ± 0.06
302.716 ± 0.18419.26 ± 1.30
602.349 ± 0.32930.87 ± 1.85

Rutin153.412 ± 0.193
303.201 ± 0.104##3.92 ± 0.57
602.825 ± 0.18415.81 ± 2.68

Kaempferol153.462 ± 0.161
303.186 ± 0.252##4.38 ± 1.02
602.629 ± 0.17722.02 ± 3.93

Luteolin153.329 ± 0.202
303.341 ± 0.175
603.420 ± 0.330

Quercetin153.186 ± 0.268##4.39 ± 0.75
302.337 ± 0.22431.26 ± 2.11
601.798 ± 0.21848.28 ± 2.74

Mollugin153.348 ± 0.152
303.350 ± 0.183
603.425 ± 0.159

Butylphthalide153.029 ± 0.249##9.36 ± 1.01
302.366 ± 0.04830.33 ± 2.77
601.367 ± 0.16461.93 ± 3.51

Aesculetin152.426 ± 0.24528.44 ± 4.01
301.979 ± 0.12242.55 ± 3.14
601.277 ± 0.27364.90 ± 4.21

Compared with the blank control group (, ); compared with the model group (, ).